Indicators

Markets:

News

Latest News about IMGN

Recent news which mentions IMGN

< Previous 1 2 3 4 5 6 Next >

Ardelyx To Rally 160%? Here Are 10 Other Price Target Changes For Friday

December 30, 2022

ImmunoGen's Newly Approved Ovarian Cancer Drug Listed As Preferred Regime

December 28, 2022

Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors

December 02, 2022

Looking Into Immunogen's Return On Capital Employed

November 28, 2022

Why Jim Cramer Sees 'Another Bad Quarter Ahead' For Ford, And What Will Turn Things Around

November 23, 2022

After FDA Approval For Ovarian Cancer Drug, ImmunoGen Becomes Top Pick For This Analyst

November 16, 2022

Expert Ratings for Immunogen

November 16, 2022

Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday

November 16, 2022

Vodafone, Getty Images Holdings, Haynes International And Some Other Big Stocks Moving Lower On Tuesday

November 15, 2022

PDS Biotechnology To Rally Around 129%? Here Are 5 Other Price Target Changes For Tuesday

November 15, 2022

HUYA, Tencent Music Entertainment, Taiwan Semiconductor Manufacturing, And Some Other Big Stocks Moving Higher In Today's Pre-Market Session

November 15, 2022

FDA Grants Conditional Approval To First Antibody Drug Conjugate From ImmunoGen For Pretreated Ovarian Cancer

November 15, 2022

Recap: Immunogen Q3 Earnings

November 04, 2022

Earnings Scheduled For November 4, 2022

November 04, 2022

Preview: Immunogen's Earnings

November 03, 2022

Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know

November 01, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022

September 09, 2022

Short Volatility Alert: ImmunoGen, Inc.

August 31, 2022

ImmunoGen (IMGN) Q2 2022 Earnings Call Transcript

July 30, 2022

12 Health Care Stocks Moving In Friday's Intraday Session

July 29, 2022

Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update

July 29, 2022

Recap: Immunogen Q2 Earnings

July 29, 2022

Earnings Scheduled For July 29, 2022

July 29, 2022

Earnings Preview For Immunogen

July 28, 2022

12 Health Care Stocks Moving In Tuesday's After-Market Session

July 19, 2022

Immunogen's Return On Capital Employed Overview

May 31, 2022

12 Health Care Stocks Moving In Friday's Pre-Market Session

May 27, 2022

What's Going On With ImmunoGen Shares Today?

May 23, 2022

ImmunoGen (IMGN) Q1 2022 Earnings Call Transcript

May 06, 2022

Immunogen: Q1 Earnings Insights

May 06, 2022

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.